Quince Therapeutics, Inc. Financial and Nonfinancial Liabilities, Fair Value Disclosure
Quince Therapeutics, Inc. (QNCX) had Financial and Nonfinancial Liabilities, Fair Value Disclosure of $6.29 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Fair Value Disclosures › Fair Value, Net Asset (Liability)
us-gaap:LiabilitiesFairValueDisclosure · last filed 2026-08-14
- 2026-06-30: Financial and Nonfinancial Liabilities, Fair Value Disclosure $6.29M.
- 2026-03-31: Financial and Nonfinancial Liabilities, Fair Value Disclosure $694.00K.
- 2025-12-31: Financial and Nonfinancial Liabilities, Fair Value Disclosure $114.51M.
- 2025-09-30: Financial and Nonfinancial Liabilities, Fair Value Disclosure $93.59M.
| Period end | Financial and Nonfinancial Liabilities, Fair Value Disclosure |
|---|---|
| 2026-06-30 | $6.29M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $694.00K 10-Q · filed 2026-05-11 |
| 2025-12-31 | $114.51M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $93.59M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $91.28M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $73.88M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $71.01M 10-K · filed 2026-04-10 |
| 2024-09-30 | $69.69M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $76.31M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $73.77M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $71.14M 10-K · filed 2025-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |